Related Experiment Video
Updated: Jun 28, 2025

10:28
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.1K
Development of a Prognostic Model for Gastric Cancer Based on Apoptosis- and Hypoxia-Related Genes: Predictive
1Department of General Surgery, First People's Hospital of Linping District, Hangzhou 311100, China.
Summary
This study developed a prognostic model using apoptosis and hypoxia-related genes (AHRGs) to predict gastric cancer (GC) survival. The AHRG score effectively identified patient risk groups and potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Gastric cancer (GC) is a leading cause of cancer death with poor prognosis.
- Apoptosis and hypoxia play crucial roles in GC development and progression.
Purpose of the Study:
- To identify and validate apoptosis and hypoxia-related genes (AHRGs) as prognostic markers for gastric cancer.
- To develop a predictive model for gastric cancer prognosis based on AHRGs.
Main Methods:
- Differential gene expression analysis on TCGA GC data.
- Construction and validation of a prognostic model using regression analyses and external datasets.
- Clustering of tumor samples and analysis of immune landscape and chemosensitivity.
Main Results:
- A robust prognostic model based on AHRGs was established and validated.
- The AHRG risk score independently predicted GC prognosis and was used to create a nomogram.
- Distinct molecular subtypes with varying prognoses, immune profiles, and therapeutic sensitivities were identified.
Conclusions:
- The AHRG scoring system offers a novel and effective method for predicting GC prognosis.
- This approach can guide personalized treatment strategies and identify potential therapeutic targets for gastric cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K

